Ideal for mid-size organisations.

Streamlining pharma packaging with unparalleled oversight & safety

GLAMS Enterprise is a tailored solution for medium to large pharmaceutical companies.Prioritising accurate labelling and artwork's vital role in patient safety, it offers a validated system that globallytracks all labelling details. Exclusively designed for the pharma sector, GLAMS Enterprise ensures compliance whileproviding real-time project insights, simplifying daily challenges.

Revolutionising pharma label management foroptimal compliance and global efficiency


Managing labelling and artwork in the pharmaceutical industry, with its intricate compliance requirements and potential consequences of errors, can be daunting. A misstep can lead to fines, recalls, or worse. GLAMS Enterprise is a solution tailored for medium to large firms, providing a validated system to efficiently oversee all labelling changes both locally and globally. Designed exclusively for pharma, GLAMS Enterprise ensures patient safety while offering real-time project updates, addressing the industry's daily challenges head-on.

Revolutionising pharmaceutical labeling change management

A single unified view of Regulatory and Artwork files and metadata

Discover

GLAMS Impact Analysis streamlines change management by using advanced algorithms and NLP to efficiently identify tracked changes in drug product labeling documents, saving time and effort in assessing affected assets.

Define

Offers comprehensive tools to assess the impact of identified changes on artwork files, including modifications to text, format, and visuals. Its documentation features ensure clear understanding of the impact on artwork content.

Implement

Enhances change management by seamlessly integrating with your AMS. It automates the transfer of changes from labeling documents to artwork, minimising errors and enabling efficient workflows and notifications for artwork updates.

Auto-initiate

Workflow in AMS

The Impact Analysis Solution auto-initiates workflows post-analysis, promptly notifying stakeholders for enhanced collaboration, faster task execution, and regulatory visibility during artwork updates.

Find out more about

reducing your artwork

proof cycle by 70%

We help Life Science companies design, manage and deliver packaging artwork, marcoms and digital assets


Quality Guaranteed


Patient safety and risk mitigation are our primary focus: our culture of operational excellence, GMP/GAMP compliant processes and the development of our Quality Management Systems are all guided by this principal.

All services provided by Perigord, both regionally and globally, are certified to ISO 9001:2015, PS 9000:2016 and are compliant to 21 CFR Part 11 & Eudralex Volume 4, Annex 11. Beyond these global standards, Perigord is audited on a rolling basis by our customers: in 2018, Perigord was audited by 15 of the top 20 global Life Science companies passing all audits with distinction.
Read More

About us


Servicing the Global Life Science industry we are headquartered in Dublin, Ireland, with four Centres of Creative and Packaging Excellence across the globe in Dublin Ireland, Waldkirch Germany, Connecticut USA and Hyderabad India and regional sales and account management support offices in Massachusetts, New York and California in the USA and Christchurch New Zealand.
Read More

Latest News


By Adriana Medina April 23, 2025
Designed specifically for the Life Science Industry, this version of our GLAMS AMS solution ensures that Perigord maintains its leadership position as the go-to provider of the world's leading Life Science and Pharmaceutical Artwork Management Platform. Dublin, Ireland – Perigord is proud to announce the launch of GLAMS AMS 6 , the latest evolution of its Artwork Management System (AMS) built specifically for the Life Science industry. GLAMS AMS 6 is a cornerstone of our Global Life Sciences Automation Management System . Featuring the most advanced and cutting-edge capabilities, GLAMS AMS 6 helps Life Science companies address their most pressing challenges and needs in artwork creation, approval, and compliance within the industry today. With the adoption of GLAMS AMS 6, our clients can accelerate efficiency across the artwork production and approval process, significantly reducing their time-to-market. With the GLAMS AMS 6 solution, Life Science organisations can optimise processes and manage artwork production globally in a seamless and unified system. Key GLAMS AMS 6 Enhancements Include: State-of-the-Art UX Upgrades: Intuitive interface designed for faster, more accessible, and easier navigation and searching across the platform, now complemented by an AI assistant tool for improved user support. Faster Response Times: Enhanced performance for quicker processing and a smoother user experience. Strengthened BI Reporting: Advanced reporting capabilities providing comprehensive insights into every stage of the artwork lifecycle. Expanded Stamping Capabilities: Flexible, configurable options for document approval stamps to ensure clarity and compliance. Upgraded Linked Workflow Creation and Integration: Seamless creation and management of complex hierarchical workflows for more accurate project tracking and efficiency. File View and Navigation without Download: Enables quicker, more efficient interaction with artwork files, reducing the need for downloads. Real-Time Task Dependency Refinements: Improved visibility into task interdependencies, promoting better collaboration and reducing bottlenecks. Automated Decision-Based Workflow Advancements: Automation of workflow paths based on data and decisions made as the process progresses, increasing efficiency and accuracy in the critical path without manual intervention. Integrated Subscription-Based Notification Centre: Real-time, on-screen notifications allowing more efficient interaction with workflows. Enhanced User Permission Administration: Offering efficiencies to handle whole-user base access permissions in just a few clicks. GLAMS AMS 6 builds upon the foundation of previous releases while introducing new advanced features that set it apart from other AMS solutions. GLAMS AMS 6 helps companies enhance productivity, reduce artwork approval time, and maintain regulatory compliance – ensuring a faster and more efficient time-to-market for critical products. " The launch of GLAMS AMS 6 is a major milestone for us, further solidifying our position as the industry’s leading Artwork Management solution provider ,” says Suzanne Ivory, Chief Operations Officer, Perigord . “ Through close collaboration with some of the world’s top Pharmaceutical and Life Science organisations, we've developed a solution that makes workflows more efficient, reduces delays in packaging development, and helps teams manage and approve artwork with speed and full compliance. " Sam Cole, Director of Client Services, Perigord , adds, “ The new enhancements in GLAMS AMS 6 have been designed to offer a truly automated, scalable, and compliant solution that integrates seamlessly with existing systems, optimising key processes at every stage of the packaging and labelling workflow. These improvements are a direct result of our ongoing efforts to support Life Science organisations in managing more complex global regulatory requirements while improving operational efficiency. ” About GLAMS AMS GLAMS AMS is the only Artwork Management System developed specifically for the Life Science industry, addressing the unique challenges associated with artwork creation, approvals, and regulatory compliance. By leveraging automated workflows, advanced integration with existing business systems, and powerful reporting tools, GLAMS AMS helps clients in the Life Sciences industry minimise risk, streamline approval cycles, and accelerate product launches across multiple regulatory regions simultaneously. Available now, GLAMS AMS 6 is ready to help businesses evolve their artwork and labelling management with greater speed, security, and compliance. Request a demo at: www.GLAMS.com For more information contact your GLAMS Account Manager or: Mark Ennis Global Business Development Director mark.ennis@perigord-as.com Perigord Life Science Solutions Unit 1, Lyncon Court IDA Business & Technology Park Snugborough Road, Blanchardstown Dublin, D15 N283, Ireland mediarelations@perigord-as.com Tel: +353 1 440 3222 www.GLAMS.com
By Gary Orr April 1, 2025
Advanced Artwork and Labelling Production Analytics White Paper Pharmaceutical Artwork Departments can accelerate business impact with Advanced Artwork and Labelling Production Analytics (AALPA)
By Adriana Medina April 1, 2025
Best Practice White Paper for Remote Auditing in a GMP Environment Since 2020, auditing as we know it has changed. In-person audits are increasingly being replaced by remote audits. Read our guide to a successful remote audit.
By Gary Orr April 1, 2024
Selecting a Strategic Outsourcing Artwork and Labelling Partner White Paper Enhancing Value and Mitigating Risk by Outsourcing to A Subject Matter Expert Organisation – A Best Practice White Paper